NUS (NuSkin Enterprises, Inc.) Stock Analysis - SEC Filings

NuSkin Enterprises, Inc. (NUS) is a publicly traded Consumer Defensive sector company. As of May 21, 2026, NUS trades at $5.84 with a market cap of $284.51M and a P/E ratio of 5.18. NUS moved +2.46% today. Year to date, NUS is -39.73%; over the trailing twelve months it is -23.06%. Its 52-week range spans $5.32 to $14.62. Rallies surfaces NUS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Where can I find NUS SEC filings?

Rallies organizes NUS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.

NUS Key Metrics

Key financial metrics for NUS
MetricValue
Price$5.84
Market Cap$284.51M
P/E Ratio5.18
EPS$1.13
Dividend Yield0.06%
52-Week High$14.62
52-Week Low$5.32
Volume121
Avg Volume0
Revenue (TTM)$1.44B
Net Income$54.52M
Gross Margin69.31%

Latest NUS News

Recent NUS Insider Trades

  • Nathanson Laura sold 2.68K (~$18.01K) on May 11, 2026.
  • Hatchett Steven Keith bought 5.50K (~$52.85K) on Nov 11, 2025.
  • Nathanson Laura sold 6.49K (~$79.30K) on Sep 4, 2025.

NUS Analyst Consensus

NUS analyst coverage data. Average price target: $0.00.

Common questions about NUS

Where can I find NUS SEC filings?
Rallies organizes NUS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
Does Rallies show NUS 10-K and 10-Q filings?
Rallies organizes NUS SEC filing research, including 10-K reports, 10-Q reports, company disclosures, and filing-driven context when available.
Is NUS research on Rallies investment advice?
No. Rallies provides research, data, and educational context for NUS. It does not provide personalized investment advice.
NUS

NUS